Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients

Supportive Care in Cancer

Volumn 21, Issue 11, 2013, Pages 3223-3232

  Jensen, Siri Beier ^a   Jarvis, Virginia ^b   Zadik, Yehuda ^c,d   Barasch, Andrei ^e   Ariyawardana, Anura ^f,g   Hovan, Allan ^h   Yarom, Noam ^i,j   Lalla, Rajesh V ^k   Bowen, Joanne ^l   Elad, Sharon ^m  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c ISRAELI AIR FORCE   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

^f JAMES COOK UNIVERSITY   (Australia)

^g GRIFFITH UNIVERSITY   (Australia)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j TEL AVIV UNIVERSITY   (Israel)

^k UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^l UNIVERSITY OF ADELAIDE   (Australia)

^m UNIVERSITY OF ROCHESTER   (United States)

more..

Author keywords

Cancer therapy; Oral mucositis; Palliative; Prevention; Saliva; Supportive; Treatment

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; BETHANECHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CYTOTOXIC AGENT; FLUOROURACIL; GLYCEROL; HERBACEOUS AGENT; MISCELLANEOUS DRUGS AND AGENTS; MUSCARINIC AGENT; PAYAYOR; PENTOXIFYLLINE; PILOCARPINE; PLACEBO; PREDNISONE; PROPANTHELINE BROMIDE; TETRACHLORODECAOXIDE; UNCLASSIFIED DRUG; XANTHAN;

BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHEWING GUM; CRYOTHERAPY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ORAL MUCOSITIS; OROPHARYNGEAL MUCOSITIS; PATIENT CARE PLANNING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION PROTECTION; RETROSPECTIVE STUDY; REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; WHOLE BODY RADIATION;

ALLOPURINOL; ANTIMETABOLITES; CHEMORADIOTHERAPY; CHEWING GUM; HEAD AND NECK NEOPLASMS; HUMANS; MUSCARINIC AGONISTS; PRACTICE GUIDELINES AS TOPIC; RADIATION-PROTECTIVE AGENTS; STOMATITIS;

EID: 84885647606     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1884-6     Document Type: Review

References (51)

1. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5):820-831
2. Lalla RV (2013) The MASCC/ISOO mucositis guidelines update: introduction to the first set of articles. Support Care Cancer 21(1):301-302
3. Bowen JM, Elad S, Hutchins RD, Lalla RV (2013) Methodology for the MASCC/ISOO mucositis clinical practice guidelines update. Support Care Cancer 21(1):303-308
4. Elad S, Bowen J, Zadik Y, Lalla RV (2013) Development of the MASCC/ISOO clinical practice guidelines for mucositis: considerations underlying the process. Support Care Cancer 21(1):309-312
5. Gibson RJ, Keefe DM, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJ, Yazbeck R, Elad S, Bowen JM (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21(1):313-326
6. Nicolatou-Galitis O, Sarri T, Bowen J, Di PM, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV (2013) Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):357-364
7. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):333-341
8. Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21(1):327-332
9. Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV (2013) Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):343-355
10. Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749-754
11. Somerfield MR, Einhaus K, Hagerty KL, Brouwers MC, Seidenfeld J, Lyman GH (2008) American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. J Clin Oncol 26(24):4022-4026
12. Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV, For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) (2013) Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer. doi: 10.1007/s00520-013-1869-5
13. Howell SB, Wung WE, Taetle R, Hussain F, Romine JS (1981) Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer 48(6):1281-1289
14. Kroener JF, Saleh F, Howell SB (1982) 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer. Cancer Treat Rep 66(5):1133-1137
15. Howell SB, Pfeifle CE, Wung WE (1983) Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection. Cancer 51(2):220-225
16. Yokomizo H, Yoshimatsu K, Hashimoto M, Ishibashi K, Umehara A, Yoshida K, Fujimoto T, Watanabe K, Ogawa K (2004) Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis. Anticancer Res 24(2C):1131-1134
17. Panahi Y, Ala S, Saeedi M, Okhovatian A, Bazzaz N, Naghizadeh MM (2010) Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. Eur J Cancer Care (Engl) 19(3):308-312
18. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM (1990) A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 65(8):1879-1882
19. Clark PI, Slevin ML (1985) Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Eur J Surg Oncol 11(3):267-268
20. Tsavaris N, Caragiauris P, Kosmidis P (1988) Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Eur J Surg Oncol 14(5):405-406
21. Tsavaris NB, Komitsopoulou P, Tzannou I, Loucatou P, Tsaroucha-Noutsou A, Kilafis G, Kosmidis P (1991) Decreased oral toxicity with the local use of allopurinol in patients who received high dose 5-fluorouracil. Sel Cancer Ther 7(3):113-117
22. Elzawawy A (1991) Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes. Oncology 48(4):282-284
23. Van der Vliet W, Erlichman C, Elhakim T (1989) Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis. Clin Pharm 8(9):655-658
24. Porta C, Moroni M, Nastasi G (1994) Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis. Am J Clin Oncol 17(3):246-247
25. Perch SJ, Machtay M, Markiewicz DA, Kligerman MM (1995) Decreased acute toxicity by using midline mucosa-sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx, and nasopharynx. Radiology 197(3):863-866
26. Putwatana P, Sanmanowong P, Oonprasertpong L, Junda T, Pitiporn S, Narkwong L (2009) Relief of radiation-induced oral mucositis in head and neck cancer. Cancer Nurs 32(1):82-87
27. Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J (1993) Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 82(3):732-736
28. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW (1991) Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78(5):1205-1211
29. van der Jagt RH, Pari G, McDiarmid SA, Boisvert DM, Huebsch LB (1994) Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 13(2):203-207
30. Ferra C, de Sanjose S, Lastra CF, Marti F, Marino EL, Sureda A, Brunet S, Gallardo D, Berlanga JJ, Garcia J, Granena A (1997) Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplant 20(12):1075-1080
31. Stockschlader M, Kalhs P, Peters S, Zeller W, Kruger W, Kabisch H, Lechner K, Zander A (1993) Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 12(4):357-362
32. Verdi CJ, Garewal HS, Koenig LM, Vaughn B, Burkhead T (1995) A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80(1):36-42
33. Goyal M, Shukla P, Gupta D, Bisht SS, Dhawan A, Gupta S, Pant MC, Verma NS (2009) Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study. Int J Radiat Biol 85(6):504-509
34. Bjarnason GA, Mackenzie RG, Nabid A, Hodson ID, El-Sayed S, Grimard L, Brundage M, Wright J, Hay J, Ganguly P, Leong C, Wilson J, Jordan RC, Walker M, Tu D, Parulekar W (2009) Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys 73(1):166-172
35. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, Jackson W, Delapenha RA, Shiroky J, Baum BJ (1991) Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 151(6):1149-1152
36. Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N (2006) Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol 4(5):252-258
37. Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ (2002) A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 54(1):9-13
38. Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, Frenette G (2005) Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplant 35(7):713-720
39. Awidi A, Homsi U, Kakail RI, Mubarak A, Hassan A, Kelta M, Martinez P, Sulaiti S, Al QA, Jamhoury A, Daniel M, Charles C, Ambrose A, El-Aloosy AS (2001) Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur J Cancer 37(16):2010-2014
40. Jham BC, Chen H, Carvalho AL, Freire AR (2009) A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. JOral Sci 51(4):565-572
41. Gandemer V, Le Deley MC, Dollfus C, Auvrignon A, Bonnaure-Mallet M, Duval M, De LL, Hartmann O, Mechinaud F, Sirvent N, Orbach D, Doireau V, Boutard P, Dalle JH, Reguerre Y, Pautard B, Aubier F, Schneider P, Suc A, Couillaut G, Schmitt C (2007) Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 29(2):86-94
42. Ahmed T, Engelking C, Szalyga J, Helson L, Coombe N, Cook P, Corbi D, Puccio C, Chun H, Mittelman A (1993) Propantheline prevention of mucositis from etoposide. Bone Marrow Transplant 12(2):131-132
43. Oblon DJ, Paul SR, Oblon MB, Malik S (1997) Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation. Bone Marrow Transplant 20(11):961-963
44. Sato A, Saisho-Hattori T, Koizumi Y, Minegishi M, Iinuma K, Imaizumi M (2006) Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy. Tohoku J Exp Med 210(4):315-320
45. Malik IA, Moid I, Haq S, Sabih M (1997) A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. J Pain Symptom Manage 14(2):82-87
46. Schwartz PM, Handschumacher RE (1979) Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro. Cancer Res 39(8):3095-3101
47. Berne M, Gustavsson B, Almersjo O, Spears CP, Waldenstrom J (1987) Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver. Cancer Chemother Pharmacol 20(3):193-197
48. Pedersen AM, Bardow A, Jensen SB, Nauntofte B (2002) Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 8(3):117-129
49. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010) Clinical management of salivary gland hypofunction and xerostomia in head and neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 78(4):983-991
50. Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B (2008) Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncology 44(2):162-173
51. Amaral TMP, Campos CC, Santos TPM, Leles CR, Teixeira AL, Teixeira MM, Bittencourt H, Silva TA (2012) Effect of salivary stimulation therapies on salivary flow and chemotherapy-induced mucositis: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol 113(5):628-637